Literature DB >> 19780886

Effect of baicalin and octreotide on the expression levels of P-selectin protein in multiple organs of rats with severe acute pancreatitis.

Xiping Zhang1, Guanghua Feng, Jun Jiang, Hua Tian, Li Chen, Yang Cai, Yuemin Shou, Jin Ma, Meili Ma, Feibo Zhu.   

Abstract

AIM: To investigate the effect of baicalin and octreotide on the expression levels of P-selectin protein in multiple organs of rats with severe acute pancreatitis and explore the underlying mechanism.
METHODS: Rats were randomly divided into sham-operated, model control, baicalin-treated and octreotide-treated groups. At 3, 6 and 12 h after operation, the mortality rates of rats, the contents of plasma endotoxin as well as serum NO and ET-1, the pathological changes in multiple organs, and the expression levels of P-selectin protein in each group were observed.
RESULTS: At 12 h after operation, the mortality rates of rats in treated groups were significantly lower than that in the model control group (P < 0.05), and the pathological severity scores in multiple organs in treated groups were also significantly lower than those in the model control group (P < 0.05). The contents of plasma endotoxin, serum PLA(2) (at 6 and 12 h after operation), ET-1 and NO (at 3 and 12 h after operation) in treated groups were significantly lower than those in the model control group (P < 0.05, P < 0.01 or P < 0.001). In the baicalin-treated group, the expression levels of P-selectin protein in liver (at 3 h after operation), kidney (at 3 and 6 h after operation), pancreas, lung and spleen were significantly lower than those in the model control group (P < 0.01). In the octreotide-treated group, the expression levels of this protein in lung, intestinal mucosa (at 6 and 12 h after operation), lymph nodes (at 3 and 6 h after operation), spleen and thymus were significantly lower than those in the model control group (P < 0.05). Additionally, the products of the staining intensity and positive rate of P-selectin protein in pancreas, spleen (at 3 h after operation), intestinal mucosa (at 6 h after operation), thymus (at 6 h after operation) and lung (at 6 h after operation) in treated groups were significantly lower than those in the model control group (P < 0.05).
CONCLUSION: Both baicalin and octreotide can exert some protective effects on multiple organs and the former is superior to the latter in protecting pancreas. Furthermore, decreasing the expression levels of P-selectin protein in these organs is one of the possible mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780886     DOI: 10.1111/j.1440-1746.2009.05902.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.

Authors:  Changfeng Hu; Yiqi Wang; Yongsheng Fan; Haichang Li; Chunyan Wang; Jida Zhang; Shuijuan Zhang; Xianlin Han; Chengping Wen
Journal:  AAPS J       Date:  2015-03-12       Impact factor: 4.009

2.  Inhibitory effect of baicalin on iNOS and NO expression in intestinal mucosa of rats with acute endotoxemia.

Authors:  Aiwen Feng; Guangrong Zhou; Xiaoming Yuan; Xinli Huang; Zhengyuan Zhang; Ti Zhang
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

3.  Octreotide Attenuates Acute Kidney Injury after Hepatic Ischemia and Reperfusion by Enhancing Autophagy.

Authors:  Huiping Sun; Shuangfa Zou; Keith A Candiotti; Yanhua Peng; Qinya Zhang; Weiqiang Xiao; Yiyun Wen; Jiao Wu; Jinfeng Yang
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 4.  Phytoceuticals in Acute Pancreatitis: Targeting the Balance between Apoptosis and Necrosis.

Authors:  Laura Gaman; Dorin Dragos; Adelina Vlad; Georgiana Catalina Robu; Mugurel Petrinel Radoi; Laura Stroica; Mihaela Badea; Marilena Gilca
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-04       Impact factor: 2.629

5.  Da-Cheng-Qi Decoction Alleviates Intestinal Injury in Rats with Severe Acute Pancreatitis by Inhibiting the JAK2-STAT3 Signaling Pathway.

Authors:  Wenyin Jin; Yinfeng Shen
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-14       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.